5-Hydroxytryptamine-interacting drugs in animal models of anxiety disorders: More than 30 years of research
- 1 January 1995
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 65 (3), 319-395
- https://doi.org/10.1016/0163-7258(95)98597-j
Abstract
No abstract availableKeywords
This publication has 306 references indexed in Scilit:
- WAY 100289: Pharmacological profile of a novel 5‐HT3 receptor antagonistDrug Development Research, 1993
- Mianserin-induced 5-HT2 receptor downregulation results in anxiolytic effects in the elevated plus-maze testDrug Development Research, 1992
- Effects of buspirone and other anxiolytics on punished key-pecking in the pigeonDrug Development Research, 1991
- Preclinical anxiolytic versus antipsychotic profiles of the 5‐HT3 antagonists ondansetron, zacopride, 3α‐tropanyl‐1H‐indole‐3‐carboxylic acid ester, and 1αH, 3α, 5αH‐tropan‐3‐yl‐3,5‐dichlorobenzoateDrug Development Research, 1991
- Cork gnawing in the rat as a screening method for buspirone-like anxiolyticsDrug Development Research, 1991
- Effect of serotoninergic drugs on stress-induced hyperthermia (SIH) in miceJournal of Neural Transmission, 1990
- Effects of buspirone in the geller-seifter conflict test with incremental shockDrug Development Research, 1990
- Fear-enhanced acoustic startle is not attenuated by acute or chronic imipramine treatment in ratsPsychopharmacology, 1985
- Role of 5-hydroxytryptamine in amphetamine effects on punished and unpunished behaviourPsychopharmacology, 1983
- Lack of central 5-hydroxytryptamine influence on the anticonflict activity of diazepamPsychopharmacology, 1982